(Q52531979)

2 May 2018

title

Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson's disease. (English)

1 reference

2 May 2018

1 reference

1 reference

1 reference

4

Soininen H

1 reference

2 May 2018

Riekkinen M

1

1 reference

2 May 2018

Kejonen K

series ordinal

2

1 reference

2 May 2018

Jäkälä P

series ordinal

3

1 reference

2 May 2018

Riekkinen P Jr

series ordinal

5

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

2 May 2018

European Journal of Neuroscience

published in

1 reference

2 May 2018

volume

10

1 reference

2 May 2018

issue

4

1 reference

2 May 2018

page(s)

1429-1435

1 reference

2 May 2018

Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

The performance on learning tasks of patients in the early stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

The neural correlates of the noradrenergic modulation of human attention, arousal and learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Clonidine and diazepam have differential effects on tests of attention and learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Cognitive deficits in the early stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Planning and spatial working memory following frontal lobe lesions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

21 January 2018

Orienting of attention

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Effects of oral clonidine premedication on concentrations of cortisol and monoamine neurotransmitters and their metabolites in cerebrospinal fluid and plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Covert orientation of visual attention in Parkinson's disease: An impairment in the maintenance of attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

Covert orienting attention in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.1998.00145.X

10.1046/J.1460-9568.1998.00145.X

21 January 2018

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018